Oestrogen levels fluctuate throughout the menstrual cycle in women. Recent findings suggest these hormonal changes may influence the ability of drugs to penetrate the brain.
This discovery highlights the importance of considering hormonal cycles when designing and administering treatments that target the brain in women. Adjusting drug delivery based on oestrogen levels could improve therapeutic outcomes.











